ClinicalTrials.gg
CompletedNCT03582228BRAVEUpdated Apr 16, 2019

Bridging Recovery Allies in Virtual Environments

An interventional study of Virtual Envrionment for Social Communication in Traumatic Brain Injury, sponsored by The University of Texas Health Science Center, Houston. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-04-16.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The Bridging Recovery Allies in Virtual Environments (BRAVE) study aims to evaluate the acceptability and feasibility of implementing a virtual environment (VE) social support group for social communication training among adults with traumatic brain injury (TBI).

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • Virtual Environments
  • Social Communication
03

In context

Brain Injuries, Traumatic

1,818 studies on the registry are indexed under Brain Injuries, Traumatic; 460 are open to participants now.

This study's enrollment of 13 is below the median of 55 across 1,158 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 897 studies on the registry; 214 are open to participants now.

Of its 173 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects with a traumatic brain injury
  • between the age of 18 and 80
  • living in the community
  • able to read and speak English,
  • are more than 1-year post-injury
  • are accessible by phone,
  • report independent computer usage over the last 6 months
  • have access to a computer meeting minimum specifications for the Learning in Virtual Environments (LIVE) platform (requires Windows)
  • have broadband Internet connection,
  • achieve a Galveston Orientation Assessment Test (GOAT) score >75 to ensure appropriate levels of cognition for the study
  • and score >93.8 on the Western Battery Aphasia-Revised (WAB-R) scale to indicate sufficient communicative abilities to participate in a social support group and exit interview group.
  • able to understand and independently consent for the study and provide written consent prior to enrollment in the study

Exclusion criteria

Exclusion Criteria:

- verbal communication impairments will be excluded as measured by the WAB-R, as this study intends to focus on persons with social communication deficits rather than verbal deficits.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Virtual Envrionment for Social Communication

    Once the intervention begins, participants will meet online from home for one-hour sessions twice a week (twelve sessions over six weeks). Weekly sessions will follow a standardized format: * 15 minutes- Social support group (guided discussion of experiences related to weekly topic) * 20 minutes- Didactic instruction * 15 minutes- Role playing * 10 minutes- Debriefing and group feedback

    Behavioral: Virtual Envrionment for Social Communication

Interventions

  • BehavioralVirtual Envrionment for Social Communication

    Once the Virtual Envrionment for Social Communication intervention begins, participants will meet online from home for one-hour sessions twice a week (twelve sessions over six weeks). Weekly sessions will follow a standardized format: * 15 minutes- Social support group (guided discussion of experiences related to weekly topic) * 20 minutes- Didactic instruction * 15 minutes- Role playing * 10 minutes- Debriefing and group feedback

06

What researchers measure

Primary outcomes

  1. Perceived Usability as Assessed by the System Usability Scale (SUS)

    Scores on the System Usability Scale (SUS) range from 0-100, with higher scores indicating greater usability (which is the desired outcome).

    Time frame: about 1 week after the end of the intervention

  2. Acceptability as Assessed by the Acceptability E-Scale

    Scores on the Acceptability E-scale range from 6-30, with higher scores indicating greater acceptability (which is the desired outcome).

    Time frame: about 1 week after the end of the intervention

  3. Feasibility as Assessed by Participation Rate

    Scores on the LaTrobe Social Communication Questionnaire (LCQ) range from 30-120, with lower score indicating less social communication impairment (which is the desired outcome).

    Time frame: from the start of the intervention to the end of the intervention (6 weeks)

  4. Feasibility as Assessed by Attrition Rate

    Time frame: from the start of the intervention to the end of the intervention (6 weeks)

Secondary outcomes

  1. Change in Social Communication as Assessed by the LaTrobe Communication Questionnaire (LCQ)

    Time frame: baseline, about 1 week after the end of the intervention

07

Study locations

2 sites
  • The University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
  • TIRR Memorial Hermann
    Houston, Texas 77584, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2018 to primary completion in Jan 2019, 5 months.

Of 491 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 64. This study's 5 months is below that.

Counting every sponsor, half of 515 studies reached it within 36 months; a quarter within 21 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2018
First posted
Jul 10, 2018
StartActual
Aug 6, 2018
Primary completionActual
Jan 30, 2019
CompletionActual
Jan 30, 2019
Last update
Apr 16, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03582228
Collaborators
The Institute for Rehabilitaion and Research Foundation
Responsible party
Hilary Nicole Touchett (Doctoral Student, Robert Wood Johnson Foundation Future of Nursing Scholar, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Jul 10, 2018
Start date
Aug 6, 2018
Primary completion
Jan 30, 2019
Completion
Jan 30, 2019
Last update
Apr 16, 2019

Study contacts

Hilary N Touchett, PhD(c)
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion